Thyroid Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults (18 years or older) who have been diagnosed — either recently or in the past — with a type of tumour called a neuroendocrine neoplasm (NEN), which can appear in organs such as the lungs, gut, pancreas, thyroid, adrenal glands, or pituitary gland.
- People with a diagnosis where only one NEN-type tumour runs in the family, such as familial pituitary tumours, familial tumours of the adrenal glands or nearby nerve tissue, familial overactive parathyroid glands, familial gastrointestinal stromal tumours, or a rare condition causing abnormal growth linked to the X chromosome.
- People diagnosed with a broader medical syndrome — whether inherited or not — that is known to include NEN-type tumours, such as Multiple Endocrine Neoplasia types 1, 2, or 4, Von Hippel-Lindau syndrome, Neurofibromatosis type 1, Tuberous Sclerosis Complex, Lynch syndrome, Li-Fraumeni syndrome, Cowden syndrome, DICER1 syndrome, Carney complex, Carney-Stratakis syndrome, Carney triad, Pacak-Zhuang syndrome, or paraganglioma/pheochromocytoma/pituitary adenoma syndrome (confirm with trial site for full syndrome list).
Who may not be able to join:
- People under 18 years of age.
- People who do not wish to give their formal, documented agreement to take part in the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Laura C Hernández Ramírez, MD, PhD, Universidad Nacional Autonoma de Mexico
Phone: +525554870900
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Detection of a germline or somatic genetic defect of interest.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.